雷霆扫毒

Pfizer cuts full-year outlook due to declining sales of Covid-19-related products_我的网站

一 |     

直播吧4月21日讯 独行侠队记Tim MacMahon撰文，谈到了哈里森上任独行侠总经理后的一系列举措。

知情人士透露，独行侠长期资深医疗主管凯西-史密斯在2023年8月被解雇，结束其接近20年的独行侠生涯。    Shares of Pfizer are in retreat on the first day of trading after the drug company said sales of its COVID-19 vaccine and its coronavirus treatment are weaker than it had expected and cut revenue projections by $9 billion for the year. Falling sales of both clipped sales in the second quarter, but Pfizer said in August that it expected a rebound in the second half of 2023. Shares of Pfizer slipped more than 1% before the opening bell Monday and Moderna, which is heavily reliant on the competing vaccine it makes, slid nearly 5%. Pfizer said Friday that global usage of Paxlovid is trending slightly above last year, but that it's still below expectations.The fall vaccination period just began and the New York City drugmaker said that it's too soon to get a handle on vaccination rates for the year.Full-year revenue for Paxlovid and Comirnaty is expected to be approximately $12.5 billion, short $9 billion of what it had expected. Pfizer is lowering its full-year revenue expectations for Paxlovid by approximately $7 billion. That number also accounts for delayed commercialization of the product, which was pushed to January 2024 from the company's previous expectation of commercialization in the second half of this year. Pfizer is also lowering its 2023 revenue expectations for Comirnaty by approximately $2 billion due to lower-than-expected vaccination rates.Pfizer Inc. now foresees 2023 revenue in a range of $58 billion to $61 billion, down from its prior forecast for $67 billion to $70 billion. It now projects full-year adjusted earnings between $1.45 and $1.65 per share due to lower-than-anticipated revenue for COVID-19-related products and inventory write-offs.That is short of the full-year revenue of $63.61 billion and earnings of $2.77 per share that Wall Street was expecting, and far short of the company's previous projections of per-share earning between $3.25 and $3.45. JPMorgan said the company's update solves an ongoing U.S. Paxlovid inventory debate and it anticipates the company's bigger-than-expected cuts to its sales projections will help put a floor under per-share earnings expectations for next year.。

二 | 原因是哈里森认为史密斯“不够顺从并且态度消极”。

一位球队内部人士对此说道：“他（哈里森）完全感受到了来自史密斯的威胁，因为史密斯在球队中的话语权太重了。他要展示自己才是掌权者，没有人可以质疑这一点。”

相关新闻>>>老队医离队球队伤病潮？哈里森：他都离队2年了 进总决时咋没人问

Stein：哈里森换了球队长期资深医疗主管 但新人与团队有严重分歧。

Current article:http://p1xhbtn.xiongpeiduanlouduoennongleng.cyou/j0m/fwu7.html

Published on:06:09:27